Introduction: The objectives of this review were to assess the methodological quality of published metaanalyses related to endodontics using the assessment of multiple systematic reviews (AMSTAR) tool and to provide a follow-up to previously published reviews. Methods: Three electronic databases were searched for eligible studies according to the inclusion and exclusion criteria: Embase via Ovid, The Cochrane Library, and Scopus. The electronic search was amended by a hand search of 6 dental journals (International Endodontic Journal; Journal of Endodontics; Australian Endodontic Journal; Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology; Endodontics and Dental Traumatology; and Journal of Dental Research). The searches were conducted to include articles published after July 2009, and the deadline for inclusion of the metaanalyses was November 30, 2016. The AMSTAR assessment tool was used to evaluate the methodological quality of all included studies. Results: A total of 36 reports of meta-analyses were included. The overall quality of the meta-analyses reports was found to be medium, with an estimated mean overall AMSTAR score of 7.25 (95% confidence interval, 6.59-7.90). The most poorly assessed areas were providing an a priori design, the assessment of the status of publication, and publication bias. Conclusions: In recent publications in the field of endodontics, the overall quality of the reported meta-analyses is medium according to AMSTAR. (J Endod 2018;44:22-31) 
S ystematic reviews and meta-analyses (SRs/ MAs) are on the highest level of the evidence hierarchy scale in medical science (1) . SRs/MAs have become the benchmark for assessing and summarizing applied health research and are often used for decision making in health care (2) . However, the quality of SRs/MAs has received relatively little attention. The quality of systematic reviews with major methodological flaws can lead to false conclusions about evidence, which might have a negative impact on decision-making processes.
Several tools have been developed to assess the methodological quality of SRs/MAs. One measurement tool for the assessment of multiple systematic reviews (AMSTAR) was created based on the most commonly used instruments in the literature (3) . The AMSTAR tool assesses 11 relevant methodology domains directly related to the necessary steps to be taken when performing a systematic review. The authors of the AMSTAR checklist explicitly stated the rationale for the inclusion of each item with clear definitions and guidance on the use of the items to evaluate a systematic review. All definitions are listed in Table 1 . AMSTAR checklist items are presented in the form of questions, with possible responses of yes (item/question fully addressed), no (item/question not addressed), cannot answer (not enough information to answer the question), and not applicable. As a result, the quality of the investigated methodology of an individual SR/MA gets a cumulative numeric value from 0 to 11. AMSTAR characterizes quality at 3 levels: high, medium, and low. It has been shown to have a good inter-rater agreement, test-retest reliability, construct validity, and feasibility to assess the quality of systematic reviews, performing equally or better than similar tools in these areas (4) . Furthermore, AMSTAR has been endorsed as the best way to assess the methodological quality of SRs/MAs by the Canadian Agency for Drugs and Technologies in Health (5) .
Various studies across the medical specialties have exposed weaknesses in the quality of SRs/MAs by applying this tool (6) (7) (8) (9) . In endodontics, the overall quality of reports of meta-analyses published between January 1, 2001, and July 31, 2009, was evaluated using AMSTAR (10) . The results indicated that the overall quality of reports addressing topics related to endodontics is generally high with an AMSTAR score of 8.33 out of 11. It has been speculated that the high quality of reporting might be because of the strict implementation of well-accepted guidelines such as the Quality of Reporting of Meta-Analyses statement to improve the quality of reports (10) .
The aims of this review were to assess the methodological quality of meta-analyses related to endodontics published between August 1, 2009 , and November 30, 2016, using the AMSTAR tool and to provide a follow-up to the previously published review by Suebnukarn et al (10) .
Materials and Methods
Literature Search Three electronic databases were searched for meta-analyses related to endodontics (Embase via Ovid, The Cochrane Library, and Scopus). A specific strategy for each database was developed with the help of an experienced librarian. 
Literature Screening and Study Selection
After a review of the initial search results, a number of articles were collected and further selected based on the following inclusion and exclusion criteria:
1. The study addressed an issue related to endodontics. 2. The study was limited to human subjects. 3. The meta-analyses used statistical methods to produce a summary result. 4. The report was published in English. 5. The report of the study was first published on August 1, 2009, and November 30, 2016.
The exclusion criteria included the following:
1. Studies that failed to meet these inclusion criteria. 2. Studies for which full text was not available. 3. Studies that reported duplicate data.
According to the predetermined inclusion criteria, 2 reviewers (S.K. and S.L.) independently screened all search results by title and abstract. Subsequently, if at least 1 of the 2 reviewers deemed an article potentially relevant, the full-text version was obtained. Final inclusion for AMSTAR assessment after full-text review was resolved by discussion and consulting with a third reviewer (B.K.) if an initial agreement had not been reached. Finally, all included studies underwent data extraction and quality assessment.
Data Extraction and Quality Assessment
Data were extracted from each included study (such as the name of the author, year of publication, journal, and number of studies included in the meta-analysis) to create a table of evidence. The quality of the included studies was assessed independently by 2 reviewers (S.K. and S.L.) using the AMSTAR tool; any disagreements were resolved by discussion and consulting with a third reviewer (B.K.). Reviewers scored the compliance of each report with all 11 AMSTAR criteria including the provision of an a priori design, duplicate study selection and data extraction, comprehensive literature search, publication status used as an inclusion criterion, listing of included and excluded studies, provision of characteristics of included studies, assessment and documentation of scientific quality of included studies, appropriate use of scientific quality of included studies to formulate conclusions, appropriate methods used to combine findings, assessment of publication bias, and stated conflict of interest. According to these criteria, a score of 0 or 1 was given for each criterion, with equal weighting given to each domain. A cumulative grade was given for the article overall after conversion to a percentage scale based on the fulfillment of these 11 criteria. Final grading of the methodological quality of each study was based on the overall score and reported as either ''high,'' ''medium,'' or ''low'' in concordance with the rating system used by the Canadian Agency for Drugs and Technologies in Health (5) as follows: high quality, scores 8-11; medium quality, scores 4-7; and low quality, scores 0-3.
Data Analysis
The proportion of studies that met each of the criteria was determined and tabulated. The overall quality summary score was calculated and found to be medium. Agreement on the inclusion of studies and evaluating each study was assessed using the kappa statistic (95% confidence interval [CI]). Statistical calculations were performed using Excel 15.33 (Microsoft, Redmond, WA).
Results
A total of 1401 articles were identified by the initial electronic and hand search. After title and abstract screening, 69 full-text articles were reviewed; 36 were included and analyzed as shown in Figure 1 . Agreement among the reviewers on the inclusion of articles was high (Cohen kappa = 0.97; 95% CI, 0.92-1.02).
Characteristics of the Included Articles
All 36 articles included were published in English (100%). Two studies were Cochrane reviews (5.56% 
Methodological Quality
Agreement was reached on the scoring of all component scores and the overall quality scores (mean weighted kappa at 0.92; 95% CI, 0.83-1.00). Table 2 presents the compliance rate with each AM-STAR item. Eight items obtained a compliance rate above 50%. The item with the best compliance rate was duplicate study selection and 
TITLE-ABS-KEY (#1 AND#2 AND#3 AND#4 AND#5 AND#6 AND#7 AND#8 AND#9 AND#10 AND#11 AND#12 AND#13 AND#14 AND#15) AND (LIMIT-TO ( PUBYEAR, 2016) OR LIMIT-TO (PUBYEAR, 2015) OR LIMIT-TO (PUBYEAR, 2014) OR LIMIT-TO (PUBYEAR, 2013) OR LIMIT-TO (PUBYEAR, 2012) OR LIMIT-TO (PUBYEAR, 2011) OR LIMIT-TO (PUBYEAR, 2010) OR LIMIT-TO (PUBYEAR, 2009) ) AND (LIMIT-TO ( LANGUAGE, ''English'') ) AND (LIMIT-TO ( DOCTYPE, ''ar'') OR LIMIT-TO (DOCTYPE, ''re'') ) AND (LIMIT-TO ( SUBJAREA, ''MEDI'') OR LIMIT-TO (SUBJAREA, ''HEAL'') OR LIMIT-TO (SUBJAREA, ''DENT'') )
data extraction (n = 36, 100%), whereas the item with the worst compliance rate was whether a priori design was provided (n = 10, 27.8%). Table 2 also shows that less than half of the reports failed to provide an a priori design, report the publication status as inclusion criteria, or assess the publication of bias of the included studies. The overall quality of reports of meta-analyses published in the endodontic literature from 2009 to 2016 was found to be medium, with an estimated mean overall AMSTAR score of 7.25 (95% CI, 6.59-7.90). A total of 20 studies (55.56%) had medium quality shown by an overall score of 4 to 7, 16 studies (44.44%) had a high-quality score of 8 to 11 on the overall quality summary score, and none of the studies were identified as having a low-quality score of 0 to 3. Table 3 shows the AMSTAR scores of each included study; the weakest areas of the included meta-analyses were the provision of an a priori design, the status of publication (ie, gray literature) used as an insertion measure, and whether the probability of publication bias was assessed.
Discussion
Evaluating the methodological quality of SRs/MAs is a mean to evaluate how well the design and procedure of the research controlled bias. The AMSTAR scale has been widely used since it was published in 2007, and this scale has become a recommended tool to evaluate the methodological quality of SRs/MAs. The aims of this review were primarily to assess the methodological quality of published meta-analyses related to endodontics using the AMSTAR tool and to provide a follow-up to the previously published review by Suebnukarn et al (10) November 30, 2016 , the results show a medium overall quality of the reported meta-analyses that addressed the topics in endodontics with an estimated mean of an overall AMSTAR score of 7.25 out of 11, showing a statistically significant difference between the current review and the previous one (P < .05). This leads to the conclusion that the number of published SRs/MAs in the field of endodontics has increased in recent years, but the reporting and the methodological quality were not proven to be optimal.
Suebnukarn et al (10) included a total of 16 studies in the final analysis. Contrary to our findings, they noted that the majority of studies provided an a priori design and an assessment of the status of publication. In the present review, 36 studies published between August 2009 and November 2016 were identified and included in the final analysis. Our results showed the quality of reporting to be moderate, with only 3 studies achieving perfect scores with regard to the AMSTAR criteria (16, 19, 23) . The expertise of the primary authors in the reviewed subjects had no effect on the quality of SRs/MAs. We also found that the quality of Cochrane systematic reviews was better than that of non-Cochrane reviews selected in this study, which is consistent with the findings of the previous studies (47, 48) . This finding indicates that strict training of the methodologies and collaborative guidance among experts are beneficial for producing high-quality SRs/MAs (49) . Furthermore, the Cochrane group requires specific training with rigorous standards for methodology, which is more likely to attribute higher scoring of SRs/MAs. After assessing the results as indicated in the tables (Tables 1  and 3) , it is evident that some areas were more poorly addressed than others. The most poorly assessed area was ''the provision of an a priori design.'' This item in the AMSTAR tool requires SRs/MAs to have a protocol addressing specific questions (eg, trial inclusion and exclusion criteria, the methodological approach to be taken, and analyses that are planned). To add scientific credibility and to improve research standards, the protocol should be formulated before the SRs/MAs. A predetermined protocol is believed to reduce the possibility of publication bias and contribute to making the research process prospective, strict, and transparent. In this review, only 10 of 36 (27.8%) of the reports had a published protocol, indicating that authors should pay more attention to this area for future studies. Furthermore, registration on open-access platforms (eg, PROSPERO) is a practical way to assist researchers in complying with reporting preferred items for SRs/ MAs. Open access to registered research can allow researchers to review protocols, which is helpful to prevent duplications and selective outcome reporting biases (50) . Therefore, preregistration on an open platform with a prospective protocol should be considered for future authors before conducting SRs/MAs.
Another area that has been poorly addressed was ''the status of the publication'' as an inclusion criterion. This item is mainly used to evaluate the selection bias. Authors and journals are inclined toward publishing articles with positive outcomes while discarding those with negative outcomes that have been published mostly in informal journals. Therefore, the item tested the bias as a result of the authors' intentional or nonintentional neglect of gray literature; 36.11% (13/36) of the researchers of the reviewed articles in this study checked on the status of publication, whereas the rest of them (68.89%, 23/36) were not checked.
The assessment of publication bias is of a great importance, and the lack of proper evaluation is alarming because this is a vital element in the performance of a meta-analysis. The review herein found that the publication bias was assessed in 14 of 36 (38.89%) of the articles only. The AMSTAR checklist provides that the assessment of bias should consider the use of statistical tests such as the Egger regression test (51) and graphical tests. The simplest graphical test for publication bias is the funnel plots that provide for plotting the individual trial effect estimates against sample size (52, 53) . A symmetrically distributed plot of a large number of trials in an inverted funnel shape around an arbitrary reference point suggests an absence of publication bias. However, if publication bias is present, the plot will be asymmetrical, and it is likely to exist if the type of samples included in the studies is not representative of the population. This can be caused by language bias, availability bias, cost bias, familiarity bias, and outcome bias (54) . Publication bias may negatively affect the validity of the results under investigation (55) . Thus, the authors of SRs/MAs should take the methods to prevent publication bias seriously. Publication bias may be reduced by journals that publish high-quality studies regardless of novelty or unexciting results, protocols, or full-study data sets. No single step can be relied on to fully overcome the complex actions involved in publication bias, and a multipronged approach is required by researchers, patients, journal editors, peer reviewers, research sponsors, and research ethics committees.
There were some limitations in reporting the quality of SRs/MAs in this study. SRs/MAs written in English were only included. This language restriction may subject the study to potential publication bias. Furthermore, SRs/MAs published since August 2009 were only screened and selected as the follow-up of Suebnukarn et al (10) . Despite the best efforts of authors in this review, some articles may be missing either through the initial search or human error during the screening process. To minimize these limitations and risks in this study, 2 authors performed screening, selection, and extraction independently. In addition, high interobserver reliability was achieved by their in-depth knowledge of inclusion and exclusion criteria and prior thorough calibration. However, notwithstanding these limitations, this review evaluated the need to improve the quality of SRs/MAs in the field of endodontics.
Implications for Further Research
In recent years, the number of published SRs/MAs in the field of endodontics has increased, but the reporting and methodological quality was not proven optimal and has decreased. More effort should be expended on the assessment of the status of publication, publication bias, the provision of detailed information about the protocol and the registration process, and the implementation of additional analyses to improve the validity of the SRs/MAs. Shortcomings of the methodological quality of reports could severely affect the application of evidence, decision making, and evidence-based dentistry practice progress. To solve such problems, health professionals should consider bringing forth evidence-based curriculum into higher institutions. Researchers should consider guidelines for quality assessment, such as AMSTAR, when designing and conducting SRs/MAs to increase the validity and clinical applicability of future reviews. Furthermore, the editors and reviewers of journals should pay more attention to the general methodological quality of reports and clearly inform authors of their requirements of submitted papers to keep SRs/MAs as 1 of the best methods for achieving credible evidence in the field of endodontics.
Conclusion
In recent publications in the field of endodontics (from August 1, 2009 to November 30, 2016) , the overall quality of meta-analyses reports was found to be medium, with an estimated mean overall AMSTAR score of 7.25 out of 11. There are clear needs for authors' selfevaluation and incorporation of the AMSTAR checklist for the review process before publication.
